The week in health tech, explained in plain English.Get the free newsletter →
October 26, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

45 Hospitals and Health Systems Are Raising Worker Pay

At least 45 hospitals and health systems have announced pay raises for their workers since December 2025, according to a running tracker maintained by Becker's Hospital Review, which last updated the list on September 10.

The wave reflects sustained pressure on hospital labor costs, still the largest line item in most operating budgets. Union activity is a major driver. On September 1, more than 1,000 workers at Providence St. Vincent Medical Center in Portland, Oregon ratified their first union contract, one of several deals pushing wages higher. Systems are also raising base pay and minimum wages to compete for nurses, technicians and support staff amid persistent shortages and high turnover.

For hospital executives, the trend signals that the post-pandemic labor market has not fully cooled. Higher wages help retention and cut reliance on expensive travel and contract staff, but they also squeeze margins already strained by flat reimbursement. Expect more systems to formalize raises as unions organize and workers press for better pay.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.